Oxybutynin Chloride Extended Release
NDC 62175-270, Oxybutynin Chloride, tablet, extended release, from Lannett Company, Inc..
- Product NDC
- 62175-270
- Status
- Listed
- Labeler
- Lannett Company, Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078503
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62175-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYBUTYNIN CHLORIDE5 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62175-270-37 | 62175027037 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-37) |
| 62175-270-41 | 62175027041 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-41) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c5950dba-d92b-46a0-993f-af9f9ddb52bfNADAC price for package 62175027037
GET /v1/drugs/nadac/62175027037NADAC price for package 62175027041
GET /v1/drugs/nadac/62175027041
Use it
Look up 62175-270 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62175-270 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62175-270. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.